Gene expression in cardiac tissues from infants with idiopathic conotruncal defects

BackgroundTetralogy of Fallot (TOF) is the most commonly observed conotruncal congenital heart defect. Treatment of these patients has evolved dramatically in the last few decades, yet a genetic explanation is lacking for the failure of cardiac development for the majority of children with TOF. Our goal was to perform genome wide analyses and characterize expression patterns in cardiovascular tissue (right ventricle, pulmonary valve and pulmonary artery) obtained at the time of reconstructive surgery from 19 children with tetralogy of Fallot.MethodsWe employed genome wide gene expression microarrays to characterize cardiovascular tissue (right ventricle, pulmonary valve and pulmonary artery) obtained at the time of reconstructive surgery from 19 children with TOF (16 idiopathic and three with 22q11.2 deletions) and compared gene expression patterns to normally developing subjects.ResultsWe detected a signal from approximately 26,000 probes reflecting expression from about half of all genes, ranging from 35% to 49% of array probes in the three tissues. More than 1,000 genes had a 2-fold change in expression in the right ventricle (RV) of children with TOF as compared to the RV from matched control infants. Most of these genes were involved in compensatory functions (e.g., hypertrophy, cardiac fibrosis and cardiac dilation). However, two canonical pathways involved in spatial and temporal cell differentiation (WNT, p = 0.017 and Notch, p = 0.003) appeared to be generally suppressed.ConclusionsThe suppression of developmental networks may represent a remnant of a broad malfunction of regulatory pathways leading to inaccurate boundary formation and improper structural development in the embryonic heart. We suggest that small tissue specific genomic and/or epigenetic fluctuations could be cumulative, leading to regulatory network disruption and failure of proper cardiac development.

[1]  Xiangyi Lu,et al.  Waddington's widget: Hsp90 and the inheritance of acquired characters. , 2003, Seminars in cell & developmental biology.

[2]  Xiangyi Lu,et al.  Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution , 2003, Nature Genetics.

[3]  P. Puri,et al.  The hypoplastic heart in congenital diaphragmatic hernia: reduced expression of basic fibroblast growth factor and platelet-derived growth factor , 2000, Pediatric Surgery International.

[4]  C. Laloi,et al.  Cross-talk between singlet oxygen- and hydrogen peroxide-dependent signaling of stress responses in Arabidopsis thaliana , 2007, Proceedings of the National Academy of Sciences.

[5]  Louise Arnold,et al.  University of Missouri-Kansas City School of Medicine. , 2010, Academic medicine : journal of the Association of American Medical Colleges.

[6]  Heather L. True,et al.  Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits , 2004, Nature.

[7]  G. Corfas,et al.  Identification of Novel Glial Genes by Single-Cell Transcriptional Profiling of Bergmann Glial Cells from Mouse Cerebellum , 2010, PloS one.

[8]  D. J. Driscoll,et al.  Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. , 2005, Genomics.

[9]  B. Garvik,et al.  Principles for the Buffering of Genetic Variation , 2001, Science.

[10]  M. Butler,et al.  Whole genome microarray analysis of gene expression in subjects with fragile X syndrome , 2007, Genetics in Medicine.

[11]  G. V. Ommen,et al.  Medical genomics , 2001, European Journal of Human Genetics.

[12]  V. Hjortdal,et al.  Outcomes of pregnancy in women with tetralogy of Fallot* , 2008, Cardiology in the Young.

[13]  David L. Rimoin,et al.  Principles and Practice of Medical Genetics , 1990 .

[14]  P. Brennan,et al.  Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study , 1998, The Lancet.

[15]  B. Hogan,et al.  Distinct requirements for extra-embryonic and embryonic bone morphogenetic protein 4 in the formation of the node and primitive streak and coordination of left-right asymmetry in the mouse. , 2002, Development.

[16]  R. Erickson Principles and practice of medical genetics , 1992 .

[17]  M. Moorhouse,et al.  DNA microarray analysis for human congenital heart disease , 2006, Cell Biochemistry and Biophysics.

[18]  D. Driscoll,et al.  Prevalence of significant congenital heart defects in children of parents with Fallot's tetralogy. , 1990, The American journal of cardiology.

[19]  E. Goldmuntz,et al.  NKX2.5 mutations in patients with congenital heart disease. , 2004, Journal of the American College of Cardiology.

[20]  C. Basson,et al.  Advances in the molecular genetics of congenital structural heart disease. , 1999, Genetic testing.

[21]  B. Bruneau The developmental genetics of congenital heart disease , 2008, Nature.

[22]  Martin Vingron,et al.  Genome-Wide Array Analysis of Normal and Malformed Human Hearts , 2003, Circulation.

[23]  E. Goldmuntz,et al.  NKX2.5mutations in patients with congenital heart disease , 2003 .

[24]  D. J. Driscoll,et al.  Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.

[25]  S. Bhattacharya,et al.  Genetic Mechanisms Controlling Cardiovascular Development , 2008, Annals of the New York Academy of Sciences.

[26]  S. Korones,et al.  Congenital Heart Disease in 56,109 Births Incidence and Natural History , 1971, Circulation.

[27]  Steven Henikoff,et al.  Quantitative epigenetics , 2003, Nature Genetics.

[28]  A. Gilchrist Congenital Heart Disease , 1948, Edinburgh medical journal.

[29]  D. Bittel,et al.  Whole genome microarray analysis of gene expression in Prader–Willi syndrome , 2007, American journal of medical genetics. Part A.